A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy Participants

NCT01432938 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

BIOLOGICAL: dulaglutide
DRUG: Warfarin

Sponsor

Eli Lilly and Company